| |||||||||
Former Names B6;129S4-Gt(ROSA)26Sortm1Sho (Changed: 15-DEC-04 ) Type Mutant Stock; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Mating System Homozygote x Homozygote (Female x Male) Species laboratory mouse Generation N4F7 (08-JAN-08) Donating Investigator Stuart Orkin, Harvard Medical School Appearance
black
Related Genotype: a/aDescription
Mice with the Gtrosa26tm1Sho targeted mutation are similar to the B6;129-Gtrosa26tm1Sor from Dr. Philippe Soriano, but reported in the literature to be an improved reporter strain for monitoring cre-mediated excisions. The B-galactosidase-neomycin phosphotransferase fusion gene (Bgeo)-trapped reverse orientation splice acceptor Bgeo line 26 (ROSA26) locus was modified by gene targeting such that Bgeo is expressed only after Cre-mediated excision of loxP-flanked DNA sequences. Bgeo from the excised ROSA26 allele is expressed ubiquitously in embryos and adult mice. When mating the reporter strain with cre-expressing transgenic mice, one can see that the loxP-flanked ROSA26 allele is accessible to cre during early embryogenesis, as well as in a specific hematopoietic lineage (T lymphocytes). These mice may prove useful in the study of cell fate and cell migration during embryogenesis through recombinase-activated tagging. Homozygotes are viable and fertile.Development
The investigator modified the ROSA26 gene trap locus to engineer a reporter mouse strain suitable for in vivo assay of the function of Cre, which might be delivered as a transgene, a virus, or by microinjection. It harbors a single-copy reporter gene, eliminating potential problems such as chromosome loss associated with Cre-mediated recombination of multicopy floxed alleles. 129S4/SvJaeSor derived ROSA26 (AK7) embryonic stem (ES) cells were used.
| Control | ||
|---|---|---|
| 101045 B6129SF2/J | ||
| Considerations for Choosing Controls | ||
lacZ Expression Strains
View lacZ Expression Strains (178 strains)
Strains carrying other alleles of Bgeo
View Strains carrying other alleles of Bgeo (10 strains)
Strains carrying other alleles of Gt(ROSA)26Sor
View Strains carrying other alleles of Gt(ROSA)26Sor (49 strains)
Cre-lox Systems
Fluorescent Proteins/lacZ Systems
Genetic Quality Control Annual Report
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Bgeo relatedNeurobiology Research
Cre-lox System (loxP-flanked Sequences: Test/Reporter)
Research Tools
lacZ Expression
Cre-lox System (loxP-flanked Sequences: Test/Reporter)
Genetics Research (Mutagenesis and Transgenesis: Cre-lox System)
Genetics Research (Mutagenesis and Transgenesis: Cre-lox System: ubiquitously expressed lox-STOP-lox-LacZ transgene)
Genetics Research (Tissue/Cell Markers: Cre-lox System: ubiquitously expressed lox-STOP-lox-LacZ transgene)
Research Tools
lacZ Expression
| Allele Symbol | Gt(ROSA)26Sortm1Sho | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Stuart Orkin | ||
| Allele Type | Targeted (Reporter) | ||
| Common Name(s) | R26-beta-galfl-STOP; R26R; R26Rosa-lox-Stop-lox-LacZ; R26RstoplacZ; ROSA26-stop-lacZ; Rosa26fsLz; gtROSA; | ||
| Mutation Made By | Xiaohong Mao, Novartis | ||
| Strain of Origin | 129S4/SvJaeSor | ||
| ES Cell Line Name | AK7 | ||
| ES Cell Line Strain | 129S4/SvJaeSor | ||
| Site of Expression | when crossed to a cre recombinase-expressing strain, lacZ expression is observed in the cre-expressing tissues; this is similar to Gt(ROSA)26Sortm1Sor but has one copy of the loxP-flanked reporter gene | ||
| Expressed Gene | Bgeo, fusion of beta-galactosidase and neomycin phosphotransferase genes , E. coli | ||
| Gene Symbol and Name | Gt(ROSA)26Sor, gene trap ROSA 26, Philippe Soriano | ||
| Chromosome | 6 | ||
| Gene Common Name(s) | AV258896; Gtrgeo26; Gtrosa26; R26; ROSA26; beta geo; expressed sequence AV258896; gene trap ROSA 26; gene trap ROSA b-geo 26; | ||
| General Note | Mice carrying this mutation are considered to be reporter strains, with successful Cre excision indicated by beta-gal expression in Cre-expressing tissues. | ||
| Molecular Note | A targeting vector was designed to insert floxed (flanked by loxP) phosphoglycerate kinase-1-cytosine deaminase/phosphoglycerate kinase-1-puromycin (PGK-CD/PGK-Puro) and stop sequences between the splicing acceptor (SA) and the beta-gal-neomycin phosphotransferase fusion gene (beta-geo) sequences of the proviral ROSA 26 locus. Correctly targeted, this resulted in ES cells that were Puro resistant but G418 susceptible, and did not express beta-gal. [MGI Ref ID J:64291] | ||
Genotyping Protocols
Gt(ROSA)26Sor, Gt(ROSA)26Sortm1Sho, MCA, vers. 2
Gt(ROSA)26Sor, Gt(ROSA)26Sortm1Sho, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Mao X; Fujiwara Y; Orkin SH. 1999. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc Natl Acad Sci U S A 96(9):5037-42. [PubMed: 10220414] [MGI Ref ID J:64291]
Egan LJ; Eckmann L; Greten FR; Chae S; Li ZW; Myhre GM; Robine S; Karin M; Kagnoff MF. 2004. IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proc Natl Acad Sci U S A 101(8):2452-7. [PubMed: 14983030] [MGI Ref ID J:88644]
Xin HB; Deng KY; Rishniw M; Ji G; Kotlikoff MI. 2002. Smooth muscle expression of Cre recombinase and eGFP in transgenic mice. Physiol Genomics 10(3):211-5. [PubMed: 12209023] [MGI Ref ID J:81358]
Gt(ROSA)26Sortm1Sho relatedBerger J; Eckert S; Scardigli R; Guillemot F; Gruss P; Stoykova A. 2004. E1-Ngn2/Cre is a new line for regional activation of Cre recombinase in the developing CNS. Genesis 40(4):195-9. [PubMed: 15593326] [MGI Ref ID J:95642]
Casola S; Cattoretti G; Uyttersprot N; Koralov SB; Segal J; Hao Z; Waisman A; Egert A; Ghitza D; Rajewsky K. 2006. Tracking germinal center B cells expressing germ-line immunoglobulin gamma1 transcripts by conditional gene targeting. Proc Natl Acad Sci U S A 103(19):7396-401. [PubMed: 16651521] [MGI Ref ID J:109583]
Egawa T; Eberl G; Taniuchi I; Benlagha K; Geissmann F; Hennighausen L; Bendelac A; Littman DR. 2005. Genetic evidence supporting selection of the valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22(6):705-16. [PubMed: 15963785] [MGI Ref ID J:99111]
Garrick D; Sharpe JA; Arkell R; Dobbie L; Smith AJ; Wood WG; Higgs DR; Gibbons RJ. 2006. Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues. PLoS Genet 2(4):e58. [PubMed: 16628246] [MGI Ref ID J:115836]
Hafner M; Wenk J; Nenci A; Pasparakis M; Scharffetter-Kochanek K; Smyth N; Peters T; Kess D; Holtkotter O; Shephard P; Kudlow JE; Smola H; Haase I; Schippers A; Krieg T; Muller W. 2004. Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte-expressed protein. Genesis 38(4):176-81. [PubMed: 15083518] [MGI Ref ID J:89717]
Li Z; Chen MJ; Stacy T; Speck NA. 2006. Runx1 function in hematopoiesis is required in cells that express Tek. Blood 107(1):106-10. [PubMed: 16174759] [MGI Ref ID J:125796]
Lu TL; Chang JL; Liang CC; You LR; Chen CM. 2007. Tumor spectrum, tumor latency and tumor incidence of the pten-deficient mice. PLoS ONE 2(11):e1237. [PubMed: 18043744] [MGI Ref ID J:130367]
Peng X; Wu X; Druso JE; Wei H; Park AY; Kraus MS; Alcaraz A; Chen J; Chien S; Cerione RA; Guan JL. 2008. Cardiac developmental defects and eccentric right ventricular hypertrophy in cardiomyocyte focal adhesion kinase (FAK) conditional knockout mice. Proc Natl Acad Sci U S A 105(18):6638-43. [PubMed: 18448675] [MGI Ref ID J:134635]
Pratt T; Tian NM; Simpson TI; Mason JO; Price DJ. 2004. The winged helix transcription factor Foxg1 facilitates retinal ganglion cell axon crossing of the ventral midline in the mouse. Development 131(15):3773-84. [PubMed: 15240555] [MGI Ref ID J:92062]
Ramirez A; Page A; Gandarillas A; Zanet J; Pibre S; Vidal M; Tusell L; Genesca A; Whitaker DA; Melton DW; Jorcano JL. 2004. A keratin K5Cre transgenic line appropriate for tissue-specific or generalized Cre-mediated recombination. Genesis 39(1):52-7. [PubMed: 15124227] [MGI Ref ID J:89783]
Rivera-Feliciano J; Lee KH; Kong SW; Rajagopal S; Ma Q; Springer Z; Izumo S; Tabin CJ; Pu WT. 2006. Development of heart valves requires Gata4 expression in endothelial-derived cells. Development 133(18):3607-18. [PubMed: 16914500] [MGI Ref ID J:112458]
Schwander M; Leu M; Stumm M; Dorchies OM; Ruegg UT; Schittny J; Muller U. 2003. Beta1 integrins regulate myoblast fusion and sarcomere assembly. Dev Cell 4(5):673-85. [PubMed: 12737803] [MGI Ref ID J:129360]
Scott MM; Wylie CJ; Lerch JK; Murphy R; Lobur K; Herlitze S; Jiang W; Conlon RA; Strowbridge BW; Deneris ES. 2005. A genetic approach to access serotonin neurons for in vivo and in vitro studies. Proc Natl Acad Sci U S A 102(45):16472-7. [PubMed: 16251278] [MGI Ref ID J:103436]
Sgaier SK; Millet S; Villanueva MP; Berenshteyn F; Song C; Joyner AL. 2005. Morphogenetic and cellular movements that shape the mouse cerebellum; insights from genetic fate mapping. Neuron 45(1):27-40. [PubMed: 15629700] [MGI Ref ID J:95823]
Stenman J; Toresson H; Campbell K. 2003. Identification of two distinct progenitor populations in the lateral ganglionic eminence: implications for striatal and olfactory bulb neurogenesis. J Neurosci 23(1):167-74. [PubMed: 12514213] [MGI Ref ID J:82693]
Wrobel CN; Mutch CA; Swaminathan S; Taketo MM; Chenn A. 2007. Persistent expression of stabilized beta-catenin delays maturation of radial glial cells into intermediate progenitors. Dev Biol 309(2):285-97. [PubMed: 17706960] [MGI Ref ID J:124867]
Zadelaar SM; Boesten LS; Pires NM; van Nieuwkoop A; Biessen EA; Jukema W; Havekes LM; van Vlijmen BJ; Willems van Dijk K. 2006. Local cre-mediated gene recombination in vascular smooth muscle cells in mice. Transgenic Res 15(1):31-6. [PubMed: 16475008] [MGI Ref ID J:106456]
Zeisberg EM; Ma Q; Juraszek AL; Moses K; Schwartz RJ; Izumo S; Pu WT. 2005. Morphogenesis of the right ventricle requires myocardial expression of Gata4. J Clin Invest 115(6):1522-1531. [PubMed: 15902305] [MGI Ref ID J:99203]
Zeisberg EM; Potenta S; Xie L; Zeisberg M; Kalluri R. 2007. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 67(21):10123-8. [PubMed: 17974953] [MGI Ref ID J:127148]
Zhang DJ; Wang Q; Wei J; Baimukanova G; Buchholz F; Stewart AF; Mao X; Killeen N. 2005. Selective expression of the Cre recombinase in late-stage thymocytes using the distal promoter of the Lck gene. J Immunol 174(11):6725-31. [PubMed: 15905512] [MGI Ref ID J:99042]
Zhou B; Ma Q; Rajagopal S; Wu SM; Domian I; Rivera-Feliciano J; Jiang D; von Gise A; Ikeda S; Chien KR; Pu WT. 2008. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454(7200):109-13. [PubMed: 18568026] [MGI Ref ID J:137426]
Zhuang X; Masson J; Gingrich JA; Rayport S; Hen R. 2005. Targeted gene expression in dopamine and serotonin neurons of the mouse brain. J Neurosci Methods 143(1):27-32. [PubMed: 15763133] [MGI Ref ID J:115426]
de Alboran IM; Baena E; Martinez-A C. 2004. c-Myc-deficient B lymphocytes are resistant to spontaneous and induced cell death. Cell Death Differ 11(1):61-8. [PubMed: 12970677] [MGI Ref ID J:115648]
Animal Health Reports
Room Number AX12
Colony Maintenance
Mating System Homozygote x Homozygote (Female x Male) Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Weeks of Age Price* Gender Genotypes Provided Individual Mouse Price $152.60 Female or Male Homozygous for Gt(ROSA)26Sortm1Sho *Price(s) in US dollars ($)
Pairs /Price* Pair Genotype $305.20 Homozygous for Gt(ROSA)26Sortm1Sho x Homozygous for Gt(ROSA)26Sortm1Sho
| Supply Notes |
|
|---|
| Pricing for International shipping destinations |
|
Weeks of Age Price* Gender Genotypes Provided Individual Mouse Price $198.40 Female or Male Homozygous for Gt(ROSA)26Sortm1Sho *Price(s) in US dollars ($)
Pairs /Price* Pair Genotype $396.80 Homozygous for Gt(ROSA)26Sortm1Sho x Homozygous for Gt(ROSA)26Sortm1Sho
| Supply Notes |
|
|---|
| Standard Supply | Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of ~nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and larger quantities of mice are easily arranged. Estimated ship dates for all orders provided within 48 hours of order placement. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| 101045 B6129SF2/J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.